An overview of the new oral warfarin alternatives, an important new area in therapy for cardiovascular disease, provided by a leading expert.
Presented in a concise format
Authored by a well-known expert
Provides a user-friendly overview of the most important clinical trials
An overview of the new oral warfarin alternatives, an important new area in therapy for cardiovascular disease, provided by a leading expert.
Presented in a concise format
Authored by a well-known expert
Provides a user-friendly overview of the most important clinical trials
The coagulation pathway and approaches to anticoagulation.- Common clinical indications for anticoagulation.- The vitamin K antagonists and their limitations.- Haemorrhage risks, patient perspectives, and quality-of-life issues.- New oral anticoagulants.- Future directions.
Professor Gregory YH Lip is Professor of Cardiovascular Medicine at the University of Birmingham, and Visiting Professor of Haemostasis, Thrombosis and Vascular Sciences in the School of Life and Health Sciences at the University of Aston in Birmingham, UK.
Professor Lip is a member of the scientific documents committee of the European Heart Rhythm Association (EHRA), and serves on the board of the Working Group on Hypertension of the Heart of the European Society of Cardiology (ESC). He is also a member of the Working Groups of Thrombosis and Cardiovascular Pharmacology of the ESC.
Professor Lip has acted as Clinical Adviser for the UK National Institute for Health and Clinical Excellence (NICE) guidelines on atrial fibrillation (AF) management. He was on the writing committee for the 8th American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from the EHRA, includinlă#
![Handbook of Oral Anticoagulation [Paperback]](/itemImage/2/2/3/9/2_829846.jpg "Handbook of Oral Anticoagulation [Paperback] xxx")